Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
il y a 813
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
il y a 1080
Yen Falls Against Majors
The Japanese yen weakened against other major currencies in the Asian session on Wednesday.
RTTNews
|
il y a 1h 58min
European Shares Seen Mostly Higher At Open
European stocks are seen opening broadly higher on Wednesday as traders hope for the end of the longest government shutdown in U.S. history.
RTTNews
|
il y a 3h 33min
European Economic News Preview: Germany Final Inflation Data Due
Final inflation from Germany and industrial production from Italy are due on Wednesday, headlining a light day for the European economic news. At 2.00 am ET, Destatis is scheduled to release Germany's final inflation data for October. The flash estimate showed that consumer price inflation is forecast to ease to 2.3 percent from 2.4 percent in September.
RTTNews
|
il y a 3h 34min
Sensex, Nifty Extend Gains As IT Stocks Surge
Indian shares opened on a buoyant note Wednesday, with IT stocks surging amid positive global cues and on growing optimism over a potential trade deal with the United States.
RTTNews
|
il y a 4h 33min
Australian Market Extends Early Gains In Mid-market
The Australian stock market is extending its early gains in mid-market moves on Wednesday, reversing the losses in the previous session, with the benchmark S&P/ASX 200 staying well above the 8,800 level, following the mixed cues from Wall Street overnight, with gains in mining and energy stocks partially offset by weakness in technology stocks.
RTTNews
|
il y a 5h 59min
Asian Markets A Sea Of Green
Asian stock markets are a sea of green on Wednesday, following the mixed cues from Wall Street overnight, amid optimism about an end to the record-setting U.S. government shutdown of 42 days and expectations of the US Fed cutting interest-rate next month. Traders largely shrugged off worries about the economic impact of the shutdown. Asian markets closed mixed on Tuesday.
RTTNews
|
il y a 6h 5min
